Hemostatic effects of FmocF-ADP hydrogel consisted of Fmoc-Phenylalanine and ADP

Amino Acids. 2023 Apr;55(4):499-507. doi: 10.1007/s00726-023-03243-y. Epub 2023 Jan 30.

Abstract

During trauma and surgery, bleeding is a major concern. One of the crucial strategies for hemostasis is the use of biological hemostatic material. Herein, we reported an amino acid-based hydrogel FmocF-ADP hydrogel, which consisted of N-[(9H-fluoren-9-ylmethoxy) carbonyl]-3-phenyl-L-alanine (FmocF) and adenosine diphosphate (ADP) sodium solution. The hydrogel was created by FmocF self-assembling to nanofiber in ADP sodium solution and then cross-linking to hydrogel. FmocF-ADP hydrogel showed good in vitro coagulation activity as measured by whole blood clotting assays, platelet clotting assays, platelet activation assays, and platelet adhesion assays. Further, it was noted to reveal an exceptional in vivo hemostatic effect in a mouse liver bleeding model. Together with the previous report of the good biocompatibility and antimicrobial activity of FmocF hydrogel, our study would extend the biomedical application of FmocF hydrogel. In conclusion, the present study would provide a constructive strategy for the development of new antimicrobial and hemostatic materials or develop a potential hemostatic material.

Keywords: Adenosine diphosphate (ADP); Bleeding; FmocF-ADP hydrogel; Hemostasis; N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-phenyl-L-alanine (FmocF).

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Animals
  • Hemostasis
  • Hemostatics* / pharmacology
  • Hydrogels / pharmacology
  • Mice

Substances

  • Hemostatics
  • Fmoc-phenylalanine
  • Hydrogels
  • Adenosine Diphosphate